RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$973M
AUM Growth
+$326M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
36
New
Increased
Reduced
Closed

Top Buys

1
+$90.2M
2
+$56M
3
+$52.9M
4
RPRX
Repros Therapeutics Inc.
RPRX
+$27.8M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$20M

Top Sells

1
+$23.3M
2
+$11.6M
3
+$8.48M
4
ENZ
Enzo Biochem, Inc.
ENZ
+$6.62M
5
NVAX icon
Novavax
NVAX
+$4.88M

Sector Composition

1 Healthcare 84.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$5.57M 0.57%
527,797
-133,899
27
$5.55M 0.57%
199,398
28
$5.26M 0.54%
+44,444
29
$4.54M 0.47%
20,417
30
– –
0
31
– –
0
32
– –
0
33
– –
-2,268,653
34
– –
0
35
– –
-666,667
36
– –
0
1
2